Literature DB >> 2971751

Surface expression of only gamma delta and/or alpha beta T cell receptor heterodimers by cells with four (alpha, beta, gamma, delta) functional receptor chains.

T Saito1, F Hochstenbach, S Marusic-Galesic, A M Kruisbeek, M Brenner, R N Germain.   

Abstract

Surface expression of TCR dimers by cells synthesizing three or four distinct types of receptor chains was analyzed. Cells containing intact gamma, alpha, and beta chains had only gamma delta dimers on the cell surface. In human PEER cells, addition of a functional alpha chain led to the loss of gamma delta dimer expression and expression of only alpha beta dimers. This result was not due to transcriptional down-regulation of the gamma or delta loci. In murine cells expressing all four chains, both gamma delta and alpha beta dimers could be demonstrated on a single cell. No other chain combinations (alpha gamma, alpha delta, beta gamma, or beta delta) were detected. Thus, there is stringent control of assembly and/or transport of TCR heterodimers, such that functional receptors consist only of alpha beta and gamma delta pairs, and no additional repertoire diversity is generated by cross pairing.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2971751      PMCID: PMC2189041          DOI: 10.1084/jem.168.3.1003

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  47 in total

1.  Characteristics of a monoclonal antibody (WT-31) that recognizes a common epitope on the human T cell receptor for antigen.

Authors:  H Spits; J Borst; W Tax; P J Capel; C Terhorst; J E de Vries
Journal:  J Immunol       Date:  1985-09       Impact factor: 5.422

2.  Developmental regulation of T-cell receptor gene expression.

Authors:  D H Raulet; R D Garman; H Saito; S Tonegawa
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

3.  Analysis of cDNA clones specific for human T cells and the alpha and beta chains of the T-cell receptor heterodimer from a human T-cell line.

Authors:  Y Yanagi; A Chan; B Chin; M Minden; T W Mak
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

4.  T-cell receptor delta gene rearrangements in early thymocytes.

Authors:  Y H Chien; M Iwashima; D A Wettstein; K B Kaplan; J F Elliott; W Born; M M Davis
Journal:  Nature       Date:  1987 Dec 24-31       Impact factor: 49.962

5.  Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences.

Authors:  H Saito; D M Kranz; Y Takagaki; A C Hayday; H N Eisen; S Tonegawa
Journal:  Nature       Date:  1984 Jun 28-Jul 4       Impact factor: 49.962

6.  Somatic recombination in a murine T-cell receptor gene.

Authors:  Y H Chien; N R Gascoigne; J Kavaler; N E Lee; M M Davis
Journal:  Nature       Date:  1984 May 24-30       Impact factor: 49.962

7.  The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level.

Authors:  A Weiss; R L Wiskocil; J D Stobo
Journal:  J Immunol       Date:  1984-07       Impact factor: 5.422

8.  The murine T-cell receptor uses a limited repertoire of expressed V beta gene segments.

Authors:  R K Barth; B S Kim; N C Lan; T Hunkapiller; N Sobieck; A Winoto; H Gershenfeld; C Okada; D Hansburg; I L Weissman
Journal:  Nature       Date:  1985 Aug 8-14       Impact factor: 49.962

9.  Expression of T-cell antigen receptor genes during fetal development in the thymus.

Authors:  H R Snodgrass; Z Dembić; M Steinmetz; H von Boehmer
Journal:  Nature       Date:  1985 May 16-22       Impact factor: 49.962

10.  A human T cell-specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains.

Authors:  Y Yanagi; Y Yoshikai; K Leggett; S P Clark; I Aleksander; T W Mak
Journal:  Nature       Date:  1984 Mar 8-14       Impact factor: 49.962

View more
  13 in total

Review 1.  Newly identified gamma delta and beta delta T-cell receptors.

Authors:  F Hochstenbach; M B Brenner
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

2.  Adoptive T-cell Immunotherapy: Perfecting Self-Defenses.

Authors:  Raphaëlle Toledano Zur; Galit Adler; Katerina Shamalov; Yair Tal; Chen Ankri; Cyrille J Cohen
Journal:  Exp Suppl       Date:  2022

3.  TCRγ4δ1-engineered αβT cells exhibit effective antitumor activity.

Authors:  Kangxia He; Hongqin You; Yuxia Li; Lianxian Cui; Jianmin Zhang; Wei He
Journal:  Mol Med       Date:  2016-07-26       Impact factor: 6.354

4.  How (specific) would like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer.

Authors:  Inbal Daniel-Meshulam; Shlomo Ya'akobi; Chen Ankri; Cyrille J Cohen
Journal:  Front Immunol       Date:  2012-07-06       Impact factor: 7.561

5.  Domain-swapped T cell receptors improve the safety of TCR gene therapy.

Authors:  Michael T Bethune; Marvin H Gee; Mario Bunse; Mark S Lee; Eric H Gschweng; Meghana S Pagadala; Jing Zhou; Donghui Cheng; James R Heath; Donald B Kohn; Michael S Kuhns; Wolfgang Uckert; David Baltimore
Journal:  Elife       Date:  2016-11-08       Impact factor: 8.140

6.  RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.

Authors:  Dennis C Harrer; Bianca Simon; Shin-Ichiro Fujii; Kanako Shimizu; Ugur Uslu; Gerold Schuler; Kerstin F Gerer; Stefanie Hoyer; Jan Dörrie; Niels Schaft
Journal:  BMC Cancer       Date:  2017-08-17       Impact factor: 4.430

7.  A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release.

Authors:  Yiyang Xu; Zhiyuan Yang; Lucas H Horan; Pengbo Zhang; Lianxing Liu; Bryan Zimdahl; Shon Green; Jingwei Lu; Javier F Morales; David M Barrett; Stephan A Grupp; Vivien W Chan; Hong Liu; Cheng Liu
Journal:  Cell Discov       Date:  2018-11-20       Impact factor: 10.849

Review 8.  Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma.

Authors:  Zenan Wang; Zhan Wang; Binghao Li; Shengdong Wang; Tao Chen; Zhaoming Ye
Journal:  Front Immunol       Date:  2019-05-16       Impact factor: 7.561

9.  Human adenovirus-specific γ/δ and CD8+ T cells generated by T-cell receptor transfection to treat adenovirus infection after allogeneic stem cell transplantation.

Authors:  Jan Dörrie; Christian Krug; Christian Hofmann; Ina Müller; Verena Wellner; Ilka Knippertz; Stephan Schierer; Simone Thomas; Elke Zipperer; Dieter Printz; Gerhard Fritsch; Gerold Schuler; Niels Schaft; Rene Geyeregger
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 10.  mRNA as novel technology for passive immunotherapy.

Authors:  Thomas Schlake; Andreas Thess; Moritz Thran; Ingo Jordan
Journal:  Cell Mol Life Sci       Date:  2018-10-17       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.